COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action?

Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/31423

Title:	COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action?
Authors:	Waddell, K Wilson, MG Gauvin, François-Pierre Mansilla, C Moat, KA Wang, Q Lavis, JN
Keywords:	incremental;benefit;history;ageusia;anosmia;screening;COVID-19
Publication Date:	May-2020
Citation:	Waddell K, Wilson MG, Gauvin FP, Mansilla C, Moat KA, Wang Q, Lavis JN. COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? Hamilton: McMaster Health Forum, 14 May 2020.
Series/Report no.:	REP 9;
Abstract:	An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action in response to a decision-maker’s request.
URI:	http://hdl.handle.net/11375/31423
Appears in Collections:	Rapid evidence profiles

Files in This Item:

File	Description	Size	Format
covid-19-rep-9_loss-of-taste-smell-for-screening.pdf Open Access		321.35 kB	Adobe PDF	View/Open

This item is licensed under a Creative Commons License